Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Sopheon Terug naar discussie overzicht

Weekdraadje 17 - 2009

53 Posts
Pagina: «« 1 2 3 »» | Laatste | Omlaag ↓
  1. [verwijderd] 20 april 2009 20:26

    Frank 6.5
    Hardgaander 6.4
    Bertus 6.3
    Hans 6.0
    Vincent 6.1 GBP

    Iets voorzichtige verwachting,kan het alleen maar meevallen ;-)
    Hoop trouwens nog wel op een paar nieuwe klanten voor 7e.
    Iedereen succes !
  2. [verwijderd] 20 april 2009 20:36
    quote:

    ramsbrug schreef:

    Frank 6.5
    Hardgaander 6.4
    Bertus 6.3
    Hans 6.0
    Vincent 6.1 mln. GBP

    Iets voorzichtige verwachting,kan het alleen maar meevallen ;-)
    Hoop trouwens nog wel op een paar nieuwe klanten voor 7e.
    Iedereen succes !
  3. [verwijderd] 20 april 2009 21:16
    Hoi Marjas64

    Vorig jaar November zat je helemaal goed met die 8.1.

    Ik hoop niet dat je het mij kwalijk neemt, maar dit x hoop ik dat je er flink naast zit. (lol)

    Fijne avond nog,

    Frank.
  4. Marjas64 21 april 2009 08:20
    Frank,

    In deze tijd zou ik niet te hoog inzetten daarom heb ik voor 5,7 gekozen.

    Als het hoger uitkomt ben ik tevreden.
  5. Bertus S 21 april 2009 16:58
    Sustaining Innovation in Your Organization – How to Handle Missing the Mark: Part 3 of 6

    Posted by sopheon in April 20th 2009

    So now that you have your growth portfolio set up, you sit back, close your eyes and begin to envision the profits that your company will be enjoying. Shortly after the launch of your campaign, the figures come back to your desk and you realize that you have “missed the mark.” Your entire campaign, has failed to provide significant growth and profits and grumblings begin from below about all the unnecessary time spent on this portfolio.

    How to Avoid Missing the Mark

    Missing the mark can happen at a variety of points, from the IT Department to the Marketing Department. It is often easy to see that a product campaign has missed the mark, but identifying the location of the bottleneck can be a more difficult task. Determining where the bottleneck in innovation occurs is the first step in effective innovation management.

    Ignorance is often the main factor behind a marketing campaign that has missed the mark. The target markets may have been inaccurately pin-pointed, the actual product might not be efficient or effective in the eyes of the target consumer, or a variety of other circumstances. It is important to get accurate data regarding the effectiveness of your campaign as soon as possible, so you can determine just how on target you were with your efforts.

    While it may be difficult to change strategies mid campaign, you might be able to minimize losses and redirect efforts to more effective markets. Whether you change your target market, advertising focus, or marketing efforts on a different demographic, lower price to change your position on the value chain, or offer a different set of services to accompany your product, something must be done to increase your market presence and profit margins.

    Missing the mark is a major problem, but one that can be remedied with prompt and accurate information regarding the effectiveness of the campaign. Next week we will delve into the proper management techniques to get the most out of your potential project’s ROI with the article Manage Your Rollouts Effectively.

    Former Chief Innovation Officer at Cargill, Dr. Carol Pletcher, was a key contributor to the company’s efforts to enhance innovation management. She was responsible for developing six new product lines aimed at roadmap development with special emphasis on new product planning, food safety and quality assurance. Dr. Pletcher has been recognized by BusinessWeek

    Bertus S.
  6. [verwijderd] 21 april 2009 21:17
    quote:

    Stocklord schreef:

    Frank 6.5
    Hardgaander 6.4
    Nina 6.4
    Bertus 6.3
    Ardins1 6.3
    wilfredo 6,2
    Stocklord 6,2
    Vincent 6.1 mln. GBP
    Hans 6.0
    Nico 5,9
    Marjas64 5.7
  7. [verwijderd] 21 april 2009 22:47
    April 21, 2009

    Sopheon inKNOWvations - April 2009

    Welcome to inKNOWvations, Sopheon's monthly e-newsletter containing the latest information on business trends, benchmark data, events, and other resources to help you improve your organization's return on its investments in product innovation.

    Quotable Quotes...

    "Every great advance in science has issued from a new audacity of imagination."

    - John Dewey (1859-1952), American philosopher, psychologist, educator, social critic, political activist

    Innovation Takes Planning, Not Genius
    by George Stalk, Jr., Senior Adviser, The Boston Consulting Group of Canada Ltd. and Adjunct Professor, University of Toronto

    Behind every successful innovation is an unexpected insight. When it finds expression as a new business breakthrough, markets take off and competitors don't know what hit them. And yet, even at the best companies, most attempts at innovation fail. Lacking a systematic process for developing new ideas, organizations rely too much on the random inspiration of individuals.

    Practical Innovation is About Creating Business Value, Not More Stuff
    by John Rondy, Freelance Writer, WTN News

    Most people tend to think of innovation as invention. That is, invention is typically the creation of a revolutionary new material object that can do something useful, says Tom Koulopoulus, a Boston-based consultant and author of the new book "The Innovation Zone."



    Predicting Radical Innovation Success: Why companies that focus on pioneering rather than incremental innovations are more likely to be successful
    by Doug Hall, Author and Founder, Eureka! Ranch

    Now's the time to be bold. And by that, I mean that it's time to be a radical innovator of products, services, and business models.

    WEBINAR: Aligning People, Process, and Technology to Drive Product and Technology Innovation Performance

    Presented by Wally Slone, Vice President Business Solutions, Fresenius Medical Care



    During this free webinar you'll learn how Fresenius, the world's largest integrated provider of products and services for dialysis treatment, modeled and leveraged a powerful combination of people, process, and technology to raise the level of new-product innovation results. For more information or to register, click here.



    For more information on how Sopheon's solutions could benefit your organization, click here.

  8. [verwijderd] 22 april 2009 05:27
    Upcoming Events

    Sopheon Innovation Best Practices Webinar
    April 23
    More information

    Front End of Innovation
    Boston, MA
    May 18-20
    More information

    New Product Development Strategies
    Vienna, Austria
    June 11-12
    More information
  9. Bertus S 23 april 2009 21:43
    Sopheon's Annual General Meeting is planned to be held in London on June 16, 2009, and its Informatieve Bijeenkomst voor Aandeelhouders (IBA) in Amsterdam on June 17, 2009.

    Further information about the specific times and locations for the meetings will be posted on this site at the time that formal notices are mailed to shareholders.

    Waarvan akte.

    Bertus S.
53 Posts
Pagina: «« 1 2 3 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.846
AB InBev 2 5.294
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.569
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.997
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 32
Adomos 1 126
AdUX 2 457
Adyen 13 16.556
Aedifica 2 832
Aegon 3.257 320.169
AFC Ajax 537 7.023
Affimed NV 2 5.769
ageas 5.843 109.779
Agfa-Gevaert 13 1.867
Ahold 3.536 74.004
Air France - KLM 1.024 34.368
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.778
Alfen 12 16.663
Allfunds Group 3 1.224
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 339
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.768
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.414
AMG 965 126.317
AMS 3 73
Amsterdam Commodities 303 6.524
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.177
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.627
Arcelor Mittal 2.024 318.724
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.153
Aroundtown SA 1 183
Arrowhead Research 5 9.294
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.735
ASML 1.762 77.258
ASR Nederland 18 4.138
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.700
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 13 mei

    1. NL faillissementen april
    2. ASMI jaarvergadering
    3. Fagron jaarvergadering
  2. 14 mei

    1. B&S Group Q1-cijfers
    2. OCI Q1-cijfers
    3. Bayer Q1-cijfers
    4. Agfa-Gevaert Q1-cijfers
    5. Dui inflatie april (def)
    6. VK werkloosheid maart
    7. Dui ZEW-index economisch sentiment mei
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht